BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28246586)

  • 21. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
    Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
    Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-483-5p and miR-139-5p promote aggressiveness by targeting N-myc downstream-regulated gene family members in adrenocortical cancer.
    Agosta C; Laugier J; Guyon L; Denis J; Bertherat J; Libé R; Boisson B; Sturm N; Feige JJ; Chabre O; Cherradi N
    Int J Cancer; 2018 Aug; 143(4):944-957. PubMed ID: 29516499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer.
    Zhao H; Zhang J; Lu J; He X; Chen C; Li X; Gong L; Bao G; Fu Q; Chen S; Lin W; Shi H; Ma J; Liu X; Ma Q; Yao L
    BMC Cancer; 2008 Oct; 8():303. PubMed ID: 18940011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of B-Cell Translocation Gene 1 by Promoter Methylation in Colorectal Carcinoma.
    Jung YY; Sung JY; Kim JY; Kim HS
    Anticancer Res; 2018 Feb; 38(2):691-697. PubMed ID: 29374692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of N-Myc Downstream-Regulated Gene 2 in Bladder Cancer and Its Potential Utility as a Urinary Diagnostic Biomarker.
    Zhang M; Ren B; Li Z; Niu W; Wang Y
    Med Sci Monit; 2017 Sep; 23():4644-4649. PubMed ID: 28953854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A quantitative analysis of N-myc downstream regulated gene 2 (NDRG 2) in human tissues and cell lysates by reverse-phase protein microarray.
    Park MY; Choi SC; Lee HS; Kim D; Baek KE; Kim JT; Lim JS; Yeom YI; Chung JW; Kim JW; Myung PK; Lee HG; Kim JW; Song EY
    Clin Chim Acta; 2008 Jan; 387(1-2):84-9. PubMed ID: 17936257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of NDRG2 in Human Colorectal Cancer and its Association with Prognosis.
    Chen W; Peng J; Ou Q; Wen Y; Jiang W; Deng Y; Zhao Y; Wan D; Pan Z; Fang Y
    J Cancer; 2019; 10(15):3373-3380. PubMed ID: 31293640
    [No Abstract]   [Full Text] [Related]  

  • 30. Ndrg2 promoter hypermethylation triggered by helicobacter pylori infection correlates with poor patients survival in human gastric carcinoma.
    Ling ZQ; Ge MH; Lu XX; Han J; Wu YC; Liu X; Zhu X; Hong LL
    Oncotarget; 2015 Apr; 6(10):8210-25. PubMed ID: 25823664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low expression of N-myc downstream-regulated gene 2 (NDRG2) correlates with poor prognosis in hepatoblastoma.
    Gödeke J; Luxenburger E; Trippel F; Becker K; Häberle B; Müller-Höcker J; von Schweinitz D; Kappler R
    Hepatol Int; 2016 Mar; 10(2):370-6. PubMed ID: 26646663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis.
    Lee DC; Kang YK; Kim WH; Jang YJ; Kim DJ; Park IY; Sohn BH; Sohn HA; Lee HG; Lim JS; Kim JW; Song EY; Kim DM; Lee MN; Oh GT; Kim SJ; Park KC; Yoo HS; Choi JY; Yeom YI
    Cancer Res; 2008 Jun; 68(11):4210-20. PubMed ID: 18519680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of NDRG2 in clear cell renal cell carcinoma.
    Ma J; Jin H; Wang H; Yuan J; Bao T; Jiang X; Zhang W; Zhao H; Yao L
    Biol Pharm Bull; 2008 Jul; 31(7):1316-20. PubMed ID: 18591767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and regulation of NDRG2 (N-myc downstream regulated gene 2) during the differentiation of dendritic cells.
    Choi SC; Kim KD; Kim JT; Kim JW; Yoon DY; Choe YK; Chang YS; Paik SG; Lim JS
    FEBS Lett; 2003 Oct; 553(3):413-8. PubMed ID: 14572661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of colorectal cancer relapse and prognosis by tissue mRNA levels of NDRG2.
    Chu D; Zhang Z; Li Y; Wu L; Zhang J; Wang W; Zhang J
    Mol Cancer Ther; 2011 Jan; 10(1):47-56. PubMed ID: 21220491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NDRG2 inhibition of glycolysis in liver tumor cells is regulated by SIRT1.
    Zhang L; Kang J; Xin B; Cao W
    J Gastrointest Oncol; 2023 Apr; 14(2):563-571. PubMed ID: 37201050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NDRG2 positively regulates E-cadherin expression and prolongs overall survival in colon cancer patients.
    Kim YJ; Kang HB; Yim HS; Kim JH; Kim JW
    Oncol Rep; 2013 Oct; 30(4):1890-8. PubMed ID: 23900729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colorectal Cancer Cell Differentiation Is Dependent on the Repression of Aerobic Glycolysis by NDRG2-TXNIP Axis.
    Hu J; Feng L; Ren M; Zhao Y; Lu G; Lu X; Li Y; Wang X; Bu X; Wang S; Shen L; He S
    Dig Dis Sci; 2022 Aug; 67(8):3763-3772. PubMed ID: 34373985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low NDRG2, regulated by the MYC/MIZ-1 complex and methylation, predicts poor outcomes in DLBCL patients.
    Wu S; Zhang J; Chen S; Zhou X; Liu Y; Hua H; Qi X; Mao Y; Young KH; Lu T
    Ann Hematol; 2024 Jun; ():. PubMed ID: 38842567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma.
    Furuta H; Kondo Y; Nakahata S; Hamasaki M; Sakoda S; Morishita K
    Biochem Biophys Res Commun; 2010 Jan; 391(4):1785-91. PubMed ID: 20045673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.